Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1A

by Davide Visigalli, Davide Visigalli, Giovanna Capodivento, Giovanna Capodivento, Abdul Basit, Roberto Fernández, Zeeshan Hamid, Barbora Pencová, Chiara Gemelli, Chiara Gemelli, Daniela Marubbi, Daniela Marubbi, Cecilia Pastorino, Cecilia Pastorino, Adrienne M. Luoma, Christian Riekel, Daniel A. Kirschner, Angelo Schenone, Angelo Schenone, José A. Fernández, Andrea Armirotti, Lucilla Nobbio, Lucilla Nobbio
Published 2020-08-01